Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Envista Holdings Corp

Healthcare US NVST

26.0USD
-0.7(2.62%)

Last update at 2026-03-10T20:18:00Z

Day Range

25.9626.90
LowHigh

52 Week Range

20.0043.29
LowHigh

Fundamentals

  • Previous Close 26.70
  • Market Cap4183.93M
  • Volume2873883
  • P/E Ratio22.40
  • Dividend Yield-%
  • EBITDA502.70M
  • Revenue TTM2581.70M
  • Revenue Per Share TTM15.66
  • Gross Profit TTM 1493.10M
  • Diluted EPS TTM1.08

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 283.90M 254.50M -30.10000M 275.50M 301.10M
Minority interest - - 0.40M 2.60M 3.30M
Net income 243.10M 263.50M 33.30M 217.60M 230.70M
Selling general administrative 1055.50M 1019.80M 1024.00M 1080.90M 1131.40M
Selling and marketing expenses - - - - -
Gross profit 1474.80M 1426.50M 1158.10M 1513.10M 1601.80M
Reconciled depreciation 162.10M 151.90M 163.10M 168.10M 130.00M
Ebit 319.20M 306.20M 33.30M 110.90M 298.40M
Ebitda 484.40M 460.50M 195.50M 279.00M 428.40M
Depreciation and amortization 165.20M 154.30M 162.20M 168.10M 130.00M
Non operating income net other 3.10M 2.40M -0.90000M - 0.00000M
Operating income 319.20M 306.20M 33.30M 110.90M 298.40M
Other operating expenses 2249.90M 2202.70M 2248.70M 2474.10M 2546.10M
Interest expense 38.40M 54.10M 62.50M 3.50M 0.00000M
Tax provision 45.90M -9.00000M -63.40000M 57.90M 70.40M
Interest income - - - 3.50M -
Net interest income -38.40000M -54.10000M -62.50000M -3.50000M -
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense 45.90M -9.00000M -63.40000M 57.90M 70.40M
Total revenue 2569.10M 2508.90M 2282.00M 2751.60M 2844.50M
Total operating expenses 1155.60M 1120.30M 1124.80M 1235.60M 1303.40M
Cost of revenue 1094.30M 1082.40M 1123.90M 1238.50M 1242.70M
Total other income expense net -35.30000M -51.70000M -63.40000M 164.60M 2.70M
Discontinued operations 5.10M 77.00M 77.00M 77.00M 77.00M
Net income from continuing ops 238.00M 263.50M 33.30M 217.60M 230.70M
Net income applicable to common shares 243.10M 340.50M 33.30M 217.60M 230.70M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 6587.00M 6574.20M 6876.00M 6158.30M 5841.60M
Intangible assets 1086.70M 1046.40M 1259.20M 1285.60M 1390.30M
Earning assets - - - - -
Other current assets 123.40M 154.30M 73.70M 69.20M 48.30M
Total liab 2380.10M 2516.20M 3155.00M 2615.50M 1015.20M
Total stockholder equity 4206.90M 4057.60M 3720.60M 3540.20M 4823.10M
Deferred long term liab - - - - 0.00000M
Other current liab 392.50M 505.80M 481.70M 418.00M 122.10M
Common stock 1.60M 1.60M 1.60M 1.60M 4901.30M
Capital stock 1.60M 1.60M 1.60M 1.60M -
Retained earnings 731.40M 466.90M 126.40M 93.10M 0.00000M
Other liab 151.30M 304.60M 408.80M 399.30M 374.20M
Good will 3496.60M 3132.00M 3430.70M 3306.00M 3325.50M
Other assets 153.70M 167.80M 0.07M 74.40M 77.40M
Cash 606.90M 1073.60M 888.90M 211.20M 0.00000M
Cash and equivalents - - - - -
Total current liabilities 1236.70M 1207.80M 1684.70M 709.20M 641.00M
Current deferred revenue 78.90M 60.10M 48.60M 52.60M 58.40M
Net debt 922.20M 386.30M 1091.90M 1326.40M -
Short term debt 537.00M 456.10M 919.30M 30.60M 243.10M
Short long term debt 510.00M 432.40M 886.80M 3.90M 0.00000M
Short long term debt total 1529.10M 1459.90M 1980.80M 1537.60M -
Other stockholder equity 3699.00M 3732.60M 3684.40M 3589.70M 4901.30M
Property plant equipment 293.60M 392.20M 303.00M 490.40M 261.60M
Total current assets 1424.60M 1835.80M 1590.50M 1001.90M 786.80M
Long term investments - - - - 0.00000M
Net tangible assets 3241.60M -120.80000M -815.50000M -1051.40000M 107.30M
Short term investments - - - - 0.00000M
Net receivables 393.50M 331.90M 361.00M 443.60M 459.80M
Long term debt 870.70M 883.40M 907.70M 1321.00M 0.00000M
Inventory 300.80M 263.80M 266.90M 277.90M 278.70M
Accounts payable 228.30M 185.80M 235.10M 208.00M 217.40M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - 0.40M 0.40M - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income -225.10000M -143.50000M -91.80000M -144.20000M -78.20000M
Additional paid in capital - - - - 0.00000M
Common stock total equity 1.60M 1.60M 1.60M 1.60M 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity 731.40M 466.90M 126.40M - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other 153.70M 167.80M 127.30M 74.40M 77.40M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 5162.40M 4738.40M 5285.50M 5156.40M 5054.80M
Capital lease obligations 148.40M 144.10M 186.30M 212.70M 0.00000M
Long term debt total 870.70M 883.40M 907.70M 1321.00M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -657.30000M 232.90M -69.10000M -78.40000M -75.50000M
Change to liabilities -88.50000M -79.30000M 31.60M -16.80000M -2.10000M
Total cashflows from investing activities -657.30000M 232.90M -69.10000M -78.40000M -75.50000M
Net borrowings -0.20000M -475.70000M 500.10M 1318.00M 1318.00M
Total cash from financing activities 12.50M -465.60000M 492.50M -107.70000M -324.60000M
Change to operating activities -176.30000M 15.10M -29.20000M -1.10000M 40.50M
Net income 243.10M 340.50M 33.30M 217.60M 230.70M
Change in cash -466.70000M 184.70M 677.70M 211.20M -324.60000M
Begin period cash flow 1073.60M 888.90M 211.20M 0.00000M 0.00000M
End period cash flow 606.90M 1073.60M 888.90M 211.20M 0.00000M
Total cash from operating activities 182.70M 391.40M 283.90M 397.50M 400.10M
Issuance of capital stock - 0.00000M 0.00000M 643.40M -
Depreciation 162.10M 151.90M 163.10M 168.10M 130.00M
Other cashflows from investing activities -637.60000M -4.60000M -21.40000M -2.20000M -3.30000M
Dividends paid - - - - 0.00000M
Change to inventory -39.90000M -66.00000M 11.90M -1.50000M -8.90000M
Change to account receivables -71.00000M -43.20000M 71.90M 12.80M -3.80000M
Sale purchase of stock 21.80M 19.50M 13.80M 643.40M 0.00000M
Other cashflows from financing activities 137.00M 10.10M 742.50M -750.80000M -324.60000M
Change to netincome 6.60M 49.10M -2.10000M 27.90M 18.40M
Capital expenditures 75.70M 54.70M 47.70M 77.80M 72.20M
Change receivables -71.00000M -43.20000M 71.90M - 0.00000M
Cash flows other operating -9.50000M -20.70000M -8.70000M - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes -462.10000M 158.70M 707.30M - 0.00000M
Change in working capital -271.70000M -173.40000M -15.20000M -6.60000M 25.70M
Stock based compensation 30.50M 28.20M 22.60M 18.40M 13.30M
Other non cash items 47.70M 34.10M 24.50M 8.90M 0.40M
Free cash flow 107.00M 336.70M 236.20M 319.70M 327.90M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NVST
Envista Holdings Corp		 -0.7 2.62% 26.00 22.40 17.30 1.57 0.95 1.89 10.49
ISRG
Intuitive Surgical Inc		 -7.71 1.56% 485.85 73.05 61.73 19.15 10.25 18.41 59.92
ESLOY
Essilor International SA		 -0.25 0.20% 122.50 35.39 24.81 3.63 2.20 4.00 16.25
ESLOF
EssilorLuxottica Société anonyme		 4.90 2.00% 249.71 35.71 25.13 3.62 2.23 4.00 16.25
BDX
Becton Dickinson and Company		 -1.58 0.95% 163.88 37.72 15.92 3.25 2.49 4.08 17.10

Reports Covered

Stock Research & News

View All

Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Envista Holdings Corp

Building E, Brea, CA, United States, 92821-6208

Key Executives

Name Title Year Born
Mr. Amir Aghdaei Pres, CEO & Director 1959
Mr. Howard H. Yu Sr. VP & CFO 1973
Mr. Mark E. Nance Sr. VP, Gen. Counsel & Sec. 1969
Mr. Patrik Eriksson Sr. VP & Pres of Nobel Biocare 1968
Mr. Jean-Claude E. Kyrillos Sr. VP and Pres of Diagnostics & Digital Solutions 1964
Juan Arbona Chief Compliance Officer NA
Mr. Mischa M. Reis Sr. VP of Strategy & Corp. Devel. 1973
Mr. Filippo Impieri Sr. VP of Emerging Markets NA
Ms. Claudia Ortiz Sr. VP of Regulatory Affairs & Quality Assurance NA
Mr. Eric Conley Sr. VP of Orthodontics NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.